<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-SML17HZ0</identifier><date>2017</date><creator>Časar, Zdenko</creator><creator>Čusak, Alen</creator><creator>Šterk, Damjan</creator><relation>documents/doc/S/URN_NBN_SI_doc-SML17HZ0_001.pdf</relation><relation>documents/doc/S/URN_NBN_SI_doc-SML17HZ0_001.txt</relation><format format_type="issue">1/2</format><format format_type="volume">7</format><format format_type="type">article</format><format format_type="extent">str. 18-23</format><identifier identifier_type="COBISSID">1359710</identifier><identifier identifier_type="ISSN">2232-416X</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-SML17HZ0</identifier><language>slv</language><publisher publisher_location="Murska Sobota">PAZU</publisher><source>Anali PAZU</source><rights>BY-NC-ND</rights><subject language_type_id="slv">heterociklične spojine</subject><subject language_type_id="eng">heterocycles</subject><subject language_type_id="slv">pirimidini</subject><subject language_type_id="eng">pyrimidines</subject><subject language_type_id="slv">rosuvastatin</subject><subject language_type_id="slv">statini</subject><subject language_type_id="eng">statins</subject><title>N-(4-(4-fluorofenil)-5-formil-6-izopropilpirimidin-2-il)-N-metilmetansulfonamida</title><title>N-(4-(4-fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide</title><title>Uporaba alilnega intermediata pri novi sintezni poti do heterocikličnega gradnika rosuvastatina</title><title>Use of allyl intermediate in novel synthetic route to rosuvastatin key heterocyclic building block</title></Record>